What is dBMEDx?
Founded in 2010, dBMEDx is dedicated to equipping medical professionals with cutting-edge diagnostic ultrasound solutions. Their primary offering, the BBS Revolution, stands out as the world's first fully automatic bladder scanner. This device eliminates the need for manual aiming, providing rapid and accurate results. Key features such as wireless functionality and automated self-diagnostics enhance clinical efficiency and reduce the risk of cross-contamination, positioning dBMEDx as a significant player in the medical device sector focused on improving patient outcomes through user-friendly technology.
How much funding has dBMEDx raised?
dBMEDx has raised a total of $3.4M across 4 funding rounds:
Private Equity
$1.1M
Private Equity
$1.3M
Private Equity
$855K
Debt
$102K
Private Equity (2013): $1.1M, investors not publicly disclosed
Private Equity (2014): $1.3M, investors not publicly disclosed
Private Equity (2015): $855K, investors not publicly disclosed
Debt (2021): $102K featuring PPP
Key Investors in dBMEDx
PPP
Public-Private Partnership
What's next for dBMEDx?
With the recent major strategic investment, dBMEDx is poised to accelerate its growth and expand its market reach. This backing is likely to fuel further research and development, enhance manufacturing capabilities, and bolster sales and marketing efforts. The company's focus on automated, user-friendly diagnostic tools suggests a strategic direction towards increasing accessibility and efficiency in healthcare settings. Future developments may include expanding the product line or forging new partnerships to integrate their technology into broader healthcare systems, solidifying their position in the diagnostic imaging market.
See full dBMEDx company page
